Stuart Rudikoff
Impact in
- Immunology top 0.5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 59
- Hematology 26
- Multiple Myeloma Research and Treatments 19
- Co-authors
- Michael PotterDavid M. HilbertJanet G. PumphreyJerrold M. WardPedro M. Fernández‐SalgueroFrank J. GonzalezJeffrey S. RubinStuart A. Aaronson
- Journals
- The Journal of Immunology (23 papers)Proceedings of the National Academy of Sciences (17 papers)The Journal of Experimental Medicine (14 papers)Biochemistry (7 papers)Immunogenetics (6 papers)
- Partner nations
- United StatesIsraelMalaysia
In The Last Decade
Stuart Rudikoff
132 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Immunology 2.7k
- Radiology, Nuclear Medicine and Imaging 2.4k
- Hematology 968
- Molecular Biology 5.1k
- Health, Toxicology and Mutagenesis 925
Countries citing papers authored by Stuart Rudikoff
This map shows the geographic impact of Stuart Rudikoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Rudikoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Rudikoff more than expected).
Fields of papers citing papers by Stuart Rudikoff
This network shows the impact of papers produced by Stuart Rudikoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Rudikoff. The network helps show where Stuart Rudikoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stuart Rudikoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 19 | |
| 2 | 1999 | 7 | |
| 3 | 1996 | 5 | |
| 4 | Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice. | 1993 | 13 |
| 5 | 1993 | 4 | |
| 6 | 1991 | 5 | |
| 7 | 1989 | 30 | |
| 8 | 1988 | 41 | |
| 9 | 1988 | 103 | |
| 10 | 1988 | 10 | |
| 11 | 1987 | 30 | |
| 12 | 1987 | 28 | |
| 13 | 1986 | 12 | |
| 14 | 1984 | 26 | |
| 15 | 1981 | 42 | |
| 16 | Antigen binding variants of the S107 mouse myeloma cell line. | 1980 | 2 |
| 17 | The structural basis of a hapten-inhibitable kappa-chain idiotype. | 1979 | 19 |
| 18 | 1976 | 23 | |
| 19 | 1975 | 18 | |
| 20 | 1974 | 206 |
About Stuart Rudikoff
Stuart Rudikoff is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology, Immunology, Molecular Biology and Immunology and Allergy, having authored 133 papers that have together received 9.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (59 papers), Glycosylation and Glycoproteins Research (53 papers), T-cell and B-cell Immunology (30 papers), Multiple Myeloma Research and Treatments (19 papers), Immune Cell Function and Interaction (13 papers), RNA and protein synthesis mechanisms (9 papers), Immunotherapy and Immune Responses (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Immunology (2.7k citations), Radiology, Nuclear Medicine and Imaging (2.4k citations), Hematology (968 citations), Molecular Biology (5.1k citations) and Health, Toxicology and Mutagenesis (925 citations). Stuart Rudikoff has collaborated with scholars based in United States, Israel and Malaysia. Frequent co-authors include Michael Potter, David M. Hilbert, Janet G. Pumphrey, Jerrold M. Ward, Pedro M. Fernández‐Salguero, Frank J. Gonzalez, Jeffrey S. Rubin, Stuart A. Aaronson, Paul W. Finch and Eduardo A. Padlan. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Biochemistry and Immunogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.